Showing results (81-90 of 365) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-typeJeeyun Lee, Cheolwon Suh, Jooryung Huh, et al.
British Journal of Haematology|April 6, 2007
Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomasJe-Jung Lee, Dong Hwan Kim, Nan Young Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2013
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapySoo-Youn Lee, Seock-Ah Im, Yeon Hee Park, et al.
Palliative & Supportive Care|March 7, 2017
Distress and body image due to altered appearance in posttreatment and active treatment of breast cancer patients and in general population controlsDanbee Kang, Eun-Kyung Choi, Im-Ryung Kim, et al.
Cancer|August 31, 2010
Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitorsMyung Hee Chang, Hee Kyung Ahn, Jeeyun Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 7, 2014
Association between socioeconomic status and altered appearance distress, body image, and quality of life among breast cancer patientsOliver Chang, Eun-Kyung Choi, Im-Ryung Kim, et al.
Oral Oncology|June 29, 2011
Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckJong-Mu Sun, Hyun Jung Jun, Young Hyeh Ko, et al.
Oncology|February 28, 2009
Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib erasHyo Song Kim, Keunchil Park, Hyun Jung Jun, et al.
Leukemia & Lymphoma|August 9, 2005
Secondary hematological malignancies after breast cancer chemotherapyMyung Joon Park, Yeon Hee Park, Heui June Ahn, et al.
Breast Cancer Research and Treatment|May 4, 2007
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerKeun Seok Lee, Hyun Cheol Chung, Seock Ah Im, et al.
Pageof 37